Skip to main content
SpringerLink
Log in

Brèves de l’AERIO

Favoriser l’angiogenèse : une nouvelle stratégie pour améliorer l’efficacité de la chimiothérapie

AERIO news in brief

Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread

  • Revue de Presse de l’AERIO / AERIO Press Review
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ebos JM, Lee CR, Cruz-Munoz W, et al. (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232–9

    Article  CAS  PubMed  Google Scholar 

  2. Eltzschig HK, Abdulla P, Hoffman E, et al. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202: 1493–505

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10: 417–27

    Article  CAS  PubMed  Google Scholar 

  4. Senkus E, Gomez H, Dirix L, et al. (2014) Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. Psychooncology 23: 173–82. http://doi.org/10.1002/pon.3384

    Google Scholar 

  5. Oktay K, Sönmezer M, Oktem O, et al. (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. The Oncologist 12: 1055–66. http://doi.org/10.1634/theoncologist.12-9-1055

    Article  CAS  PubMed  Google Scholar 

  6. Del Mastro L, Boni L, Michelotti A, et al. (2011) Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 306: 269–76. http://doi.org/10.1001/jama.2011.991

    PubMed  Google Scholar 

  7. Del Mastro L, Ceppi M, Poggio F, et al. (2014) Gonadotropinreleasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev 40: 675–83. http://doi.org/10.1016/j.ctrv.2013.12.001

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. AERIO, Paris, France

    P. Gougis & C. Bonnet

  2. Équipe du DITEP, Gustave-Roussy, 114, rue Édouard-Vaillant, F-94800, Villejuif, France

    A. Gazzah

  3. Hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, F-75014, Paris, France

    A. Cessot

Authors
  1. P. Gougis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Gazzah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Bonnet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Cessot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to P. Gougis or C. Bonnet.

Additional information

Wong PP, Demircioglu F, Ghazaly E, et al. (2015) Cancer Cell 27: 123–37

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gougis, P., Gazzah, A., Bonnet, C. et al. Brèves de l’AERIO. Oncologie 17, 271–274 (2015). https://doi.org/10.1007/s10269-015-2526-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-015-2526-z

Keywords

Search

Navigation